Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > PXMD PaxMedica > Company Executives
PXMD PaxMedica
2.160
+0.070+3.35%
Post Mkt Price
2.210
+0.050+2.31%
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. Howard J. WeismanChief Executive Officer and Director558.33K----63male08/10/2022
Mr. Zachary RomeChief Operating Officer and Director------38male08/10/2022
Mr. Stephen D. SheldonChief Financial Officer------42male08/10/2022
Mr. Michael L. DerbyExecutive Chairman of the Board406.25K----49male08/10/2022
Mr. Charles J. CasamentoIndependent Director--------male10/03/2022
Ms. Karen LaRochelleIndependent Director50.00K----55female08/10/2022
Mr. John F. CoelhoIndependent Director------53male08/10/2022
Company Overview More
PaxMedica, Inc. is an early clinical stage biopharmaceutical company. It focuses on the development of anti-purinergic therapies for the treatment of neurodevelopmental disorders, including autism spectrum disorder and Fragile X syndrome tremor-ataxia. The company was founded in April 5, 2018 and is headquartered in Woodcliff Lake, NJ.
CEO: Mr. Howard J. Weisman
Market: NASDAQ
Listing Date: 08/26/2022
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist